Cibus, Inc. (NASDAQ:CBUS - Get Free Report) was the recipient of a significant drop in short interest during the month of January. As of January 31st, there was short interest totalling 2,110,000 shares, a drop of 8.7% from the January 15th total of 2,310,000 shares. Based on an average daily volume of 166,400 shares, the short-interest ratio is currently 12.7 days. Approximately 10.2% of the company's stock are sold short.
Analyst Ratings Changes
A number of research analysts have issued reports on the company. HC Wainwright reiterated a "buy" rating and set a $25.00 price objective on shares of Cibus in a research note on Monday, November 11th. Canaccord Genuity Group lowered their price target on Cibus from $20.00 to $18.00 and set a "buy" rating for the company in a research report on Wednesday, January 22nd.
Read Our Latest Stock Analysis on Cibus
Cibus Price Performance
Cibus stock traded down $0.08 during mid-day trading on Friday, reaching $2.09. 185,979 shares of the stock traded hands, compared to its average volume of 148,482. The stock has a market capitalization of $55.17 million, a PE ratio of -0.09 and a beta of 1.82. The business's 50-day moving average is $2.67 and its 200-day moving average is $4.13. Cibus has a 12-month low of $2.05 and a 12-month high of $23.18.
Institutional Trading of Cibus
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. FMR LLC boosted its stake in shares of Cibus by 16.9% during the 3rd quarter. FMR LLC now owns 3,913,279 shares of the company's stock worth $12,757,000 after acquiring an additional 566,328 shares during the last quarter. Granby Capital Management LLC lifted its position in Cibus by 300.0% during the fourth quarter. Granby Capital Management LLC now owns 200,000 shares of the company's stock valued at $556,000 after purchasing an additional 150,000 shares in the last quarter. Renaissance Technologies LLC lifted its position in Cibus by 933.3% during the fourth quarter. Renaissance Technologies LLC now owns 127,100 shares of the company's stock valued at $353,000 after purchasing an additional 114,800 shares in the last quarter. State Street Corp increased its position in Cibus by 43.6% in the third quarter. State Street Corp now owns 307,262 shares of the company's stock worth $1,002,000 after buying an additional 93,236 shares in the last quarter. Finally, Certior Financial Group LLC purchased a new stake in Cibus in the fourth quarter worth about $236,000. 33.81% of the stock is owned by hedge funds and other institutional investors.
Cibus Company Profile
(
Get Free Report)
Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.
Featured Stories
Before you consider Cibus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cibus wasn't on the list.
While Cibus currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.